Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Ascentage Pharma Group Internat AAPG

Set alert

Price alert · AAPG

All alert types
14.46 USD -0.42 -2.85%

At close · Oct 30

14.09 -0.37 -2.54%

After hours · Oct 30, 4:00 PM ET

Bid
14.08 × 1
Ask
14.66 × 1
13.99 Day range 14.53
14.46 52-week range 34.30
YTD
-44.91%
1 year
-55.82%
Open
14.45
Prev close
14.88
Mkt cap
1.35B
Vol
15.92K
Avg vol
6.90K
EPS
-2.26
P/E
0.00
Div yield
0.00%
More statistics
Low
13.99
High
14.53
Forward P/E
-22.34
Beta
0.66
Short ratio
2.74
Inst. own
0.04%
Dividend
0.00
Ex-div date
Earnings
Mar 31, 2027
50-d avg
15.92
200-d avg
20.22
1y target
44.50

5D chart

Chart tools
Interval
1m5m15m30m

Signals (7)
NameTimeAgo
MACD: Buy SignalOct 30, 4:00 PM1 day ago
SMA: BullishOct 30, 3:40 PM2 days ago
SMA: BearishOct 30, 2:05 PM2 days ago
SMA: BullishOct 30, 1:00 PM2 days ago
RSI: OversoldOct 30, 9:30 AM2 days ago
SMA: BearishOct 29, 9:30 AM3 days ago
SMA: BullishOct 28, 9:30 AM4 days ago

Financial health

Altman Z-Score

-2.44 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -13.5×
FY 2016: -14.5×FY 2017: -12.3×FY 2018: -4.5×FY 2019: -1.1×FY 2020: -2.3×FY 2021: -2.2×FY 2022: -2.2×FY 2023: -2.4×FY 2024: -23.7×FY 2025: -13.5×
FY 2016 5y median -2.4× FY 2025
P/S 29.3×
FY 2016: 204×FY 2017: 231×FY 2018: 227×FY 2019: 110×FY 2020: 123×FY 2021: 62.9×FY 2022: 9.4×FY 2023: 9.8×FY 2024: 9.8×FY 2025: 29.3×
FY 2016 5y median 9.8× FY 2025
P/B 12.3×
FY 2016: -107×FY 2017: -11.1×FY 2018: -1.5×FY 2019: 1.8×FY 2020: 1.8×FY 2021: 1.4×FY 2022: 4.8×FY 2023: 36.0×FY 2024: 36.3×FY 2025: 12.3×
FY 2016 5y median 12.3× FY 2025
P/FCF -13.6×
FY 2016: -31.7×FY 2017: -11.4×FY 2018: -5.4×FY 2019: -3.0×FY 2020: -1.8×FY 2021: -1.7×FY 2022: -2.2×FY 2023: -2.8×FY 2024: -70.6×FY 2025: -13.6×
FY 2016 5y median -2.8× FY 2025
EV/EBITDA -14.5×
FY 2016: -10.9×FY 2017: -29.3×FY 2018: -1.9×FY 2019: -0.6×FY 2020: -1.6×FY 2021: -1.4×FY 2022: -3.0×FY 2023: -3.9×FY 2024: -42.1×FY 2025: -14.5×
FY 2016 5y median -3.9× FY 2025
EV/Sales 28.4×
FY 2016: 165×FY 2017: 230×FY 2018: 92.8×FY 2019: 56.7×FY 2020: 83.5×FY 2021: 40.6×FY 2022: 10.9×FY 2023: 13.1×FY 2024: 10.2×FY 2025: 28.4×
FY 2016 5y median 13.1× FY 2025
FCF Yield -7.4%
FY 2016: -3.2%FY 2017: -8.8%FY 2018: -18.6%FY 2019: -33.9%FY 2020: -56.3%FY 2021: -59.3%FY 2022: -45.1%FY 2023: -36.0%FY 2024: -1.4%FY 2025: -7.4%
FY 2016 5y median -36.0% FY 2025

Profitability

Gross Margin 76.4%
FY 2016: 96.6%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 85.6%FY 2020: 84.2%FY 2021: 88.1%FY 2022: 89.5%FY 2023: 86.2%FY 2024: 97.0%FY 2025: 76.4%
FY 2016 5y median 88.1% FY 2025
Operating Margin -211.1%
FY 2016: -1495.0%FY 2017: -2064.9%FY 2018: -5074.8%FY 2019: -4014.9%FY 2020: -5332.9%FY 2021: -3116.6%FY 2022: -405.2%FY 2023: -393.1%FY 2024: -37.7%FY 2025: -211.1%
FY 2016 5y median -393.1% FY 2025
Net Margin -216.5%
FY 2016: -1406.5%FY 2017: -1872.9%FY 2018: -5072.8%FY 2019: -10202.7%FY 2020: -5442.6%FY 2021: -2803.4%FY 2022: -421.0%FY 2023: -417.0%FY 2024: -41.3%FY 2025: -216.5%
FY 2016 5y median -417.0% FY 2025
ROE -91.2%
FY 2016: 738.3%FY 2017: 89.9%FY 2018: 34.1%FY 2019: -166.3%FY 2020: -80.0%FY 2021: -63.4%FY 2022: -216.1%FY 2023: -1532.1%FY 2024: -153.5%FY 2025: -91.2%
FY 2016 5y median -153.5% FY 2025
ROIC -33.3%
FY 2016: -22.2%FY 2017: -25.6%FY 2018: -29.6%FY 2019: -53.1%FY 2020: -44.1%FY 2021: -31.1%FY 2022: -34.3%FY 2023: -39.7%FY 2024: -16.6%FY 2025: -33.3%
FY 2016 5y median -33.3% FY 2025
ROA -30.5%
FY 2016: -18.2%FY 2017: -20.4%FY 2018: -28.1%FY 2019: -122.9%FY 2020: -39.1%FY 2021: -26.6%FY 2022: -31.2%FY 2023: -37.0%FY 2024: -15.5%FY 2025: -30.5%
FY 2016 5y median -30.5% FY 2025

Growth (YoY)

Revenue -43.1%
FY 2016: 0.0%FY 2017: -17.5%FY 2018: 7.6%FY 2019: 113.2%FY 2020: -14.2%FY 2021: 124.2%FY 2022: 651.4%FY 2023: 5.9%FY 2024: 341.8%FY 2025: -43.1%
FY 2016 FY 2025
Operating Income -218.9%
FY 2016: 0.0%FY 2017: -14.0%FY 2018: -164.4%FY 2019: -68.7%FY 2020: -13.9%FY 2021: -31.0%FY 2022: 2.3%FY 2023: -2.7%FY 2024: 57.6%FY 2025: -218.9%
FY 2016 FY 2025
EPS (diluted) -153.0%
FY 2016: 0.0%FY 2017: -10.1%FY 2018: -191.3%FY 2019: -319.9%FY 2020: 55.2%FY 2021: 2.2%FY 2022: -9.1%FY 2023: 2.1%FY 2024: 89.8%FY 2025: -153.0%
FY 2016 FY 2025
Free Cash Flow -785.9%
FY 2016: 0.0%FY 2017: -160.9%FY 2018: -123.4%FY 2019: -88.7%FY 2020: -59.0%FY 2021: -20.9%FY 2022: 14.4%FY 2023: 12.1%FY 2024: 82.7%FY 2025: -785.9%
FY 2016 FY 2025

Financial Health

Current Ratio 1.8×
FY 2016: 6.0×FY 2017: 5.2×FY 2018: 9.4×FY 2019: 4.5×FY 2020: 3.9×FY 2021: 5.2×FY 2022: 1.9×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Quick Ratio 1.8×
FY 2016: 6.0×FY 2017: 5.2×FY 2018: 9.4×FY 2019: 4.5×FY 2020: 3.9×FY 2021: 5.2×FY 2022: 1.8×FY 2023: 1.4×FY 2024: 1.3×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
Debt / Equity 1.5×
FY 2016: -0.1×FY 2017: -0.0×FY 2018: -0.0×FY 2019: 0.1×FY 2020: 0.6×FY 2021: 0.9×FY 2022: 4.4×FY 2023: 29.7×FY 2024: 6.3×FY 2025: 1.5×
FY 2016 5y median 4.4× FY 2025
Net Debt / EBITDA 0.4×
FY 2016: 2.5×FY 2017: 0.2×FY 2018: 2.8×FY 2019: 0.5×FY 2020: 0.8×FY 2021: 0.8×FY 2022: -0.4×FY 2023: -1.0×FY 2024: -1.8×FY 2025: 0.4×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -22.4×
FY 2016: -35.2×FY 2017: -2.3×FY 2018: -9.4×FY 2019: -136×FY 2020: -106×FY 2021: -52.0×FY 2022: -16.1×FY 2023: -9.1×FY 2024: -5.7×FY 2025: -22.4×
FY 2016 5y median -16.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31